/stocks — the workspaceLOADING
All SVRA SEC filings, by type → · Earnings date & implied move · Search inside filings
Savara Inc (SVRA) is a pharmaceutical preparations company. Piotroski F-Score 3/8. 1 insider Form 4 filings in the last 90 days. Fundamentals from SEC filings; prices are end-of-day.
What’s behind SVRA’s latest move — the size, how unusual the volume is, and the catalyst on the tape, explained and cited to the source.
End-of-day bars · delayed, not real-time · data: Databento · studies computed in your browser from these barsCharting by TradingView Lightweight Charts™
FY ending 2020-12-31 vs 2019-12-31. original 1968 formula; calibrated on manufacturers, read financials/REITs with care
No sensitivity grid: free cash flow is not positive, so the DCF gives no value at any growth or discount rate.
Estimates, not targets. The DCF treats free cash flow as cash flow to equity and divides by shares (the common retail shortcut — it skips net debt and a full WACC), so it’s a sanity-check, not a valuation opinion. All inputs are from SVRA’s SEC filings; change any assumption above and the numbers update live. Educational only — not investment advice.
A plain-English read on SVRA plus an auto-SWOT — built from SVRA's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts — a bull, a bear, a risk manager, and a PM — debate SVRA using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
↓ Download the fiscal-year statement table: XLSX · CSV · revenue, income, EPS, cash flow, balance sheet · from SEC XBRL, dated
As filed. We do not recategorize line items. Each chart plots one XBRL concept exactly as SVRA tagged it: revenue us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, net income us-gaap:NetIncomeLoss, EPS us-gaap:EarningsPerShareDiluted, period by period; a period the company did not tag on its own is left out, not estimated. A figure that disagrees with the filing is a bug in our extraction, not a policy, and we fix it: report a mismatch.
The fair-value line is SVRA’s own median P/E, P/S, P/B and P/FCF applied to each year’s fundamentals — the price its typical valuation would have implied. Where the solid line sits above the dashed one, the stock traded at a premium to its own history that year; below, a discount. This is a description of past valuation, computed from SVRA’s filings and price history — not a forecast and not investment advice. A stock can trade above or below its own median for years.
Projected from SVRA's own SEC 8-K filing history — the year-over-year reporting pattern (about 47% land the exact day, about 91% within a week, measured across 4,713 past reports). No analyst estimates and nothing invented, and every confirmed date links to the source it came from, so you can check it yourself. It upgrades the momentSVRA files or announces.
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.
Total return including reinvested dividends, from SVRA’s adjusted closing prices. Past return is not a forecast and not investment advice.
No tracked institution reported a position in SVRA in the latest 13F round.
Every registered fund files its complete portfolio with the SEC. These weights come from those filings, so each one carries the period it describes. Holdings are quarterly and filed in arrears — the figures below are as of 2026-06-30, not today.
| Fund | Weight | As of |
|---|---|---|
| IWM iShares Russell 2000 ETF | 0.03% | 2026-06-30 |
| VTI Vanguard Total Stock Market ETF | <0.01% | 2026-06-30 |
| ITOT iShares Core S&P Total US Stock Market ETF | <0.01% | 2026-06-30 |
Drawn from 39 large US equity funds we scan, not every fund in existence, so a missing fund means we do not scan it rather than that it holds none. Holdings are joined to tickers by issuer name, which does not resolve every position; what that misses is published.
1 of 5 estimators could run on SVRA's filings. A band needs at least 2.
One estimator is a point estimate, not a range, so no band and no valuation label are published for SVRA. Below is everything that was checked, so the refusal can be read rather than taken on trust.
No sector peer set is priced for SVRA, so sector medians could not fill the gaps.
Every refusal recorded for SVRA → · How often we decline, and why →
No lawmaker has disclosed a trade in SVRA under the STOCK Act.
Of 1 sale in the last ~6 months, 0 were filed with the Rule 10b5-1 box checked, set up in advance under a written trading plan; 1 was filed without it.
| Lowrance David LChief Financial Officer | SELL | $2.2M | view → |
1 of the 2 checks that ran found nothing new for SVRA; 1 found something. 2 could not run.
Each event check looks back 30 days from the date its own source was stored, read or generated, never from the date this page was built. A check that finds nothing is a measurement of that window, not a forecast, and a check that cannot be dated does not make the claim at all.
From SEC Form 4 and 13F filings. Both are backward-looking disclosures on different reporting clocks, and neither predicts price. Educational information only — not investment advice.
Head office: Yardley, Pennsylvania, United States · the company’s charter and its head office are in different states.
Source: the cover page of Savara Inc’s 10-Q filed 2026-08-11, on EDGAR. Filings checked 2026-10-23. Incorporation is where the company’s charter was filed. It is not where the business operates or earns, which no filing cover states. How this works